CT scan test for lung scarring assessment
Part of Lungs & breathing clinical trials.
This trial tests how well a CT scan and lung function tests can measure interstitial lung disease (ILD), which is long-term scarring or inflammation in the lungs. It may help doctors use these images and tests more accurately to track ILD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with interstitial lung disease (ILD).
- You can provide CT chest scan files (DICOM format).
- You also have recent lung function test results (pulmonary function tests).
- Your CT and lung function tests are close together (within about 2 weeks).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a computer program can reliably measure the amount of lung scarring on chest CT scans. It's for people with certain types of interstitial lung disease who are already scheduled for a routine CT scan.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This study follows people who are being seen for lung scarring (also called ILD) and compares them with family members without lung scarring. It helps researchers better understand how this condition changes over time and what to look for in the future.
This study tests a new imaging method that may help doctors see whether certain types of lung scarring are linked to memory and thinking issues. If you have a chronic lung condition and also notice memory problems, this scan could give more information about your condition.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.